Golin Health Expands Corporate Health Specialty With the Appointment of Lisa Johnson to Lead Offering

December 11th, 2023

Johnson joins the agency as head of U.S. corporate health.

NEW YORK (December 11th, 2023) – Interpublic Group (NYSE: IPG) agency Golin announced today the hire of Lisa Johnson to serve as executive vice president and U.S. corporate health lead for Golin’s US healthcare practice – called Golin Health.

Johnson assumed the newly created role last month and reports to Jaimee Reggio, U.S. managing director of Golin Health. Together, they will partner with the agency’s senior leadership team as the practice continues its trajectory to establishing itself as a leading corporate health agency. Johnson will also partner with the agency’s clients to help build and protect their brands, create purposeful platforms and help their executives shape health conversations that are rapidly evolving as well as assume client leadership roles for some of the agency’s largest assignments.

“We are operating in an incredibly complicated environment where companies must communicate on wide-ranging issues to an increasing set of stakeholders, all while promoting their brand purpose and values,” said Reggio. “Lisa has deep expertise in guiding clients as they address these complex conversations and a proven track record of driving results. I look forward to having her blend her corporate and healthcare expertise to support Golin Health’s clients in this dynamic space.”

In this post, Johnson will convene a matrixed team of earned media, influencer, social media, creative and data & analytics specialists who are dedicated to Golin Health’s blue-chip roster of clients. She will also align strategies with Sarah Vellozzi, U.S. corporate practice lead, to create synergies and efficiencies across the corporate communications and healthcare teams.

Johnson has a distinguished portfolio of work throughout her career that demonstrates her passion and commitment to the healthcare industry, including strategic planning, reputation management, brand building and crisis management. She has supported policy issues, including intellectual property protection, and has focused on health equity initiatives such as communications programs to support access to medicines in low and middle-income countries.

“Healthcare companies are expected to communicate their values, behaviors and impact more than ever, especially in our post-pandemic world,” said Johnson. “I am excited to build a corporate health specialty offering, rooted in data and insights, that will create compelling programs that protect and elevate corporate reputation, drive business impact and help executives gain access to the right spheres of influence.”